InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Homcy Charles J, 董事. Officer active across 2 companies, notably BridgeBio Pharma, Inc.. In total, 11 disclosures have been recorded. Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Charles J Homcy is a Director at BridgeBio Pharma, Inc. He participates in the governance of the company and in strategic decision-making. His experience in the pharmaceutical sector is an asset to the organization.